The Internet and drug safety: What are the implications for pharmacovigilance?

Drug Safety

Volumn 20, Issue 2, 1999, Pages 95-107

  Cobert, Barton ^a   Silvey, Jim ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PCSI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA BASE; DRUG INFORMATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; INTERNET; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CONFIDENTIALITY; CONSUMER PRODUCT SAFETY; DRUG APPROVAL; DRUG INDUSTRY; EUROPE; HUMANS; INTERNATIONAL COOPERATION; INTERNET; JAPAN; PERIODICALS; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WORLD HEALTH ORGANIZATION;

EID: 0033030975     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199920020-00001     Document Type: Review

References (21)

1. Pines W. The challenge of the Internet. Drug Inf J 1998; 32: 277-81
2. Cobert BL, Silvey J. The internet, adverse events and safety. Int J Pharm Med 1998; 12: 83-6
3. Zakon RH. Hobbes' Internet Timeline v4.0 [online]. Available from: URL: http://info.isoc.org/guest/zakon/Internet/History/Hit.html [Accessed 1999 Jan 6]
4. Cyberatlas Demographics [online]. Available from: URL: cyberatlas.internet.com/big_picture/demographics/demographics_index.html [Accessed 1999 Jan 6]
5. Brown E. Straight talk: what is validation? PROTOCOL, A Validation Industry Quarterly Newsletter, Spring 1996. Bridgewater (NJ): Taratec Development Corporation (data on file)
6. Digital signature [online]. Available from: URL: www.pcwebopaedia.com/digital_signature.htm [Accessed 1998 May 4]
7. US Code of Federal Regulations: 21 Chapter I Part II Electronic Records; Electronic Signatures [online]. Available from: URL: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html [Accessed 1998 Dec 21]
8. MCA News. UK Mail, 103, 4 (September/October 1997)
9. EC Council Directive 92/28/EEC Concerning the Advertising of Medicinal Products for Human Use. Official Journal of the European Communities, 1992, L113, 13 [online]. Available from: European Union Document Delivery Service http://eudor.eur-op.eu.int/ [Accessed 1998 Dec 21]
10. FDA Internet Guidance. The Pink Sheet 1997; 59 (21); 7
11. Center for Drug Evaluation and Research. Reporting regulations and guidances [online]. Available from: URL: http://www.fda.gov/cder/aers/regs.htm [Accessed 1998 Dec 21]
12. DG III-E-3Telematics Projects in Pharmaceuticals and Cosmetics [online]. Available from: URL: www3.is.eudra.org/telemat/index.htm [Accessed 1998 Dec 21]
13. Eudranet & EudraWatch Project Progress Report (January 1998, Issue 5) [online]. Available from: URL: http://www3.is.eudra.org/telemat/pdf/en319.pdf [Accessed 1998 Dec 21]
14. De Cremiers F. Efficacy Workshop, ICH 3. The Regulatory Affairs Journal, 1996 May: 360
15. Brown L. Highlights and achievements of ICH 4. Good Clinical Practice 1997 Sept/Oct; 4 (5): 25-30
16. E2B Clinical Safety Data Management: Data Elements for Transmission of Individual Case Reports. CPMP/ICH/287/95 [online]. Available from: URL: www.ich.org/ich5e.html#Safety [Accessed 1998 Dec 21]
17. International Conference on Harmonisation; Guidance on Data Elements for Transmission of Individual Case Safety Reports. US Federal Register 1998; 63 (10): 2396-2404
18. Center for Drug Evaluation and Research. AERS: concept of operations [online]. Available from: URL: http://www.fda.gov/cder/aers/concept.htm [Accessed 1998 Dec 21]
19. White C. A preliminary assessment of the impact of MEDDRA on adverse event reports and product labeling. Drug Inf J 1998 32: 347-62
20. Downes L, Mui C, Negroponte N. Unleashing the killer app: digital strategies for market dominance. Cambridge (MA): Harvard Business School Press, 1998
21. Freidman, T. The Internet wars. New York Times 1998 Apr 11; Sect. A: 11